Cardiovascular aspects of the (pro)renin receptor: Function and significance. Issue 4 (28th February 2022)

• Record Type: Journal Article
• Authors: Xu, Chuanming; Liu, Chunju; Xiong, Jianhua; Yu, Jun
• Is Part Of: FASEB journal. Volume 36:Issue 4(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-02-28
• Subjects: cardiovascular disease -- heart -- hypertension -- (pro)renin receptor -- renin‐angiotensin system -- vascular; Biology -- Periodicals; Biology, Experimental -- Periodicals; 570
• DOI: 10.1096/fj.202101649RRR
• Languages: English
• ISSNs: 0892-6638

Abstract

Abstract: Cardiovascular diseases (CVDs), including all types of disorders related to the heart or blood vessels, are the major public health problems and the leading causes of mortality globally. (Pro)renin receptor (PRR), a single transmembrane protein, is present in cardiomyocytes, vascular smooth muscle cells, and endothelial cells. PRR plays an essential role in cardiovascular homeostasis by regulating the renin‐angiotensin system and several intracellular signals such as mitogen‐activated protein kinase signaling and wnt/β‐catenin signaling in various cardiovascular cells. This review discusses the current evidence for the pathophysiological roles of the cardiac and vascular PRR. Activation of PRR in cardiomyocytes may contribute to myocardial ischemia/reperfusion injury, cardiac hypertrophy, diabetic or alcoholic cardiomyopathy, salt‐induced heart damage, and heart failure. Activation of PRR promotes vascular smooth muscle cell proliferation, endothelial cell dysfunction, neovascularization, and the progress of vascular diseases. In addition, phenotypes of animals transgenic for PRR and the hypertensive actions of PRR in the brain and kidney and the soluble PRR are also discussed. Targeting PRR in local tissues may offer benefits for patients with CVDs, including heart injury, atherosclerosis, and hypertension.